[1]TetrahedronLetters,2005,vol.46,p.8241-8244
[2]JournalofMedicinalChemistry,2016,vol.59,p.10577-10585
[3]SoftMatter,2011,vol.7,p.1426-1440
[4]RSCAdvances,2016,vol.6,p.53358-53369
90390-46-8
23222-97-1
23876-13-3
40870-59-5
80866-76-8
619-25-0
23351-05-5 | 4-(1H-Pyrrol-1-yl)benzaldehyde | AA002MUP | MFCD03822126
23441-75-0 | 4-Phenylquinazolin-2(1h)-one | AA002N5I | MFCD00221481
23530-48-5 | N-Isopropyl-4-nitrobenzenesulfonamide | AA002NIO | MFCD00458973
2363-16-8 | Methyl 4-bromo-3-nitrobenzoate | AA002NW0 | MFCD00553089
23696-28-8 | Olaquindox | AA002O3U | MFCD00210341
245439-36-5 | 4-(3-Bromophenyl)tetrahydro-2H-pyran-4-carbonitrile | AA002OEF | MFCD08277238
24621-73-6 | 4-Chloro-1H-indole-2-carboxylic acid | AA002OR3 | MFCD02664470
247109-39-3 | 3-((1,1-Dioxidotetrahydrothiophen-3-yl)amino)propanoic acid | AA002P2I | MFCD00456685
2478-35-5 | D-Glucose, O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)- | AA002PC8 | MFCD00466913
2489-05-6 | Docosanoic acid, silver(1+) salt (1:1) | AA002POI | MFCD00059001